Kurt Von Emster, Director at CRISPR Therapeutics AG (CRSP), sold 75,508 shares at $26.76 ($2.0M) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $2.0M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.76 | 37,754 | $1.0M | 50.0% |
| 2 | $26.76 | 37,754 | $1.0M | 50.0% |
| Total | $26.76 avg | 75,508 | $2.0M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |